Matthew T. Seibt's most recent trade in Acer Therapeutics Inc was a trade of 25,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 14, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acer Therapeutics Inc | Matthew T. Seibt | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Acer Therapeutics Inc | Matthew T. Seibt | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) |